NUS(NUS)
NUS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.32B | $1.47B |
| Low | $1.32B | $1.47B |
| High | $1.32B | $1.47B |
| EBITDA Avg | $118M | $133M |
| Low | $118M | $133M |
| High | $118M | $133M |
| EBIT Avg | $68M | $77M |
| Low | $68M | $77M |
| High | $68M | $77M |
| Net Income Avg | $41M | $58M |
| Low | $41M | $58M |
| High | $41M | $58M |
| EPS Avg | $0.82 | $1.16 |
| Low | $0.82 | $1.16 |
| High | $0.82 | $1.16 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $329M | $348M | $344M | $370M | $376M | $385M |
| Low | $329M | $348M | $344M | $370M | $376M | $385M |
| High | $329M | $348M | $344M | $370M | $376M | $385M |
| EBITDA Avg | $30M | $31M | $31M | $33M | $34M | $35M |
| Low | $30M | $31M | $31M | $33M | $34M | $35M |
| High | $30M | $31M | $31M | $33M | $34M | $35M |
| EBIT Avg | $17M | $18M | $18M | $19M | $20M | $20M |
| Low | $17M | $18M | $18M | $19M | $20M | $20M |
| High | $17M | $18M | $18M | $19M | $20M | $20M |
| Net Income Avg | $10M | $13M | $9M | $14M | $16M | $17M |
| Low | $10M | $13M | $9M | $14M | $16M | $17M |
| High | $10M | $13M | $9M | $14M | $16M | $17M |
| EPS Avg | $0.21 | $0.27 | $0.19 | $0.29 | $0.33 | $0.34 |
| Low | $0.21 | $0.27 | $0.19 | $0.29 | $0.33 | $0.34 |
| High | $0.21 | $0.27 | $0.19 | $0.29 | $0.33 | $0.34 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |